What is the Akums Drugs & Pharmaceuticals Ltd share price today?

The share price of NSE:AKUMS-EQ on 01 Oct 2026 (as of 15:03:00 IST) is ₹811.65.

What is the NSE:AKUMS-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:AKUMS-EQ 52 week high low range shows a high of ₹838.8 and a low of ₹409.3.

What is the Akums Drugs & Pharmaceuticals Ltd market cap?

As on 01 Oct 2026, Akums Drugs & Pharmaceuticals Ltd market cap is ₹128796000000.

What is the shareholding pattern of Akums Drugs & Pharmaceuticals Ltd Stock?

The shareholding pattern of Akums Drugs & Pharmaceuticals Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 75.26% Foreign Institutional Investors (FII): 1.91% Domestic Institutional Investors (DII): 3.67% Mutual Funds: 9.77% Retail & Others: 9.39% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Akums Drugs & Pharmaceuticals Ltd?

The Price-to-Earnings (PE) ratio of Akums Drugs & Pharmaceuticals Ltd is 44.1499, and the Price-to-Book (PB) ratio is 2.1535, as on 01 Oct 2026.

Akums Drugs & Pharmaceuticals Share Price

814.65+0.00 (+1.66%)

+84.60% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Login to analyze with FIA

1 Day

+1.66%

1 Week

+0.19%

1 Month

+7.95%

3 Month

+23.77%

6 Month

+57.89%

YTD

+79.68%

1 Year

+84.60%

5 Year

NA

10 Year

NA

Max

+12.37%

1D

1W

1M

3M

6M

YTD

1Y

5Y

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

796.30

733.15

650.25

498.80

409.30

High

818.00

825.00

838.80

About

Akums Drugs and Pharmaceuticals is a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas. As one of the Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

ZYDUSLIFENSE

CIPLANSE

LAURUSLABSNSE

MANKINDNSE

DRREDDYNSE

AUROPHARMANSE

LUPINNSE

AKUMSNSE

LTP

1W Low

1W High

Market cap (₹)

1804.1+3.1 (0.17%)

1768

1804.10

4,27,562Cr

9550+301 (3.25%)

9113.50

9557.50

2,44,572Cr

4772+4.7 (0.10%)

4702.50

4795

1,80,871Cr

1159.5+13.8 (1.20%)

1128.10

1164.80

1,13,566Cr

1340.2-3.8 (-0.28%)

1321

1344.90

1,07,770Cr

2050+66 (3.33%)

1955.10

2054.90

1,06,117Cr

2500-35 (-1.38%)

2464.50

2539.30

1,02,433Cr

1208+1.8 (0.15%)

1189

1212.70

1,00,829Cr

1692.8+16 (0.95%)

1663.10

1696

96,088Cr

2029.3-1.9 (-0.09%)

1996.30

2031.40

91,915Cr

814.65+1.55 (0.19%)

796.30

825

12,601Cr

Akums Drugs & Pharmaceuticals Share Price

814.65+0.00 (+1.66%)

+84.60% past 1 Year

Financial overview

Compounded Sales Growth

10 years10%

5 years10%

3 years6%

Last year6%

Compounded Profit Growth

10 years15%

5 years16%

3 years39%

Last year-25%

Stock Price CAGR

10 years-

5 years-

3 years-

1 year85%

Return on Equity

10 years6%

5 years2%

3 years9%

Last year8%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
10%	10%	6%	6%
15%	16%	39%	-25%
-	-	-	85%
6%	2%	9%	8%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

ZYDUSLIFE

CIPLA

LAURUSLABS

MANKIND

DRREDDY

AUROPHARMA

LUPIN

AKUMS

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,804.1	₹427562 Cr	35.35	12.07	62.82	₹11479 Cr
9,550	₹244572 Cr	83.61	34.04	128.41	₹2568 Cr
4,772	₹180871 Cr	82.93	16.72	97.06	₹2163 Cr
1,159.5	₹113566 Cr	25.16	9.42	62.53	₹5040 Cr
1,340.2	₹107770 Cr	31.97	9.77	57.87	₹3879 Cr
2,050	₹106117 Cr	97.06	6.8	29.25	₹889 Cr
2,500	₹102433 Cr	50.15	13.75	71.08	₹1913 Cr
1,208	₹100829 Cr	31.29	5.32	63.99	₹4196 Cr
1,692.8	₹96088 Cr	25.88	17.95	96.84	₹3505 Cr
2,029.3	₹91915 Cr	16.62	30.95	154.35	₹5333 Cr
814.65	₹12601 Cr	43.2	6.53	28.62	₹255 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

%

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023
₹1167 Cr	₹1158 Cr	₹1160 Cr	₹1018 Cr	₹1024 Cr	₹1056 Cr	₹1010 Cr	₹1033 Cr	₹1019 Cr	₹944 Cr	₹1083 Cr	₹1181 Cr	₹970 Cr
₹30 Cr	₹35 Cr	₹34 Cr	₹32 Cr	₹27 Cr	₹18 Cr	₹15 Cr	₹13 Cr	₹7 Cr	₹10 Cr	₹9 Cr	₹7 Cr	₹8 Cr
₹1197 Cr	₹1193 Cr	₹1194 Cr	₹1050 Cr	₹1051 Cr	₹1073 Cr	₹1025 Cr	₹1047 Cr	₹1026 Cr	₹954 Cr	₹1092 Cr	₹1188 Cr	₹978 Cr
₹1033 Cr	₹1046 Cr	₹1052 Cr	₹961 Cr	₹932 Cr	₹1002 Cr	₹934 Cr	₹947 Cr	₹925 Cr	₹975 Cr	₹1021 Cr	₹1060 Cr	₹1125 Cr
₹205 Cr	₹187 Cr	₹181 Cr	₹127 Cr	₹156 Cr	₹111 Cr	₹136 Cr	₹135 Cr	₹135 Cr	₹13 Cr	₹102 Cr	₹159 Cr	-₹117 Cr
₹25 Cr	₹24 Cr	₹24 Cr	₹23 Cr	₹23 Cr	₹5 Cr	₹5 Cr	₹12 Cr	₹13 Cr	₹12 Cr	₹12 Cr	₹14 Cr	₹12 Cr
₹139 Cr	₹121 Cr	₹100 Cr	₹66 Cr	₹96 Cr	₹75 Cr	₹91 Cr	₹92 Cr	₹87 Cr	-₹33 Cr	₹59 Cr	₹87 Cr	-₹159 Cr
₹101 Cr	₹81 Cr	₹68 Cr	₹43 Cr	₹65 Cr	₹150 Cr	₹66 Cr	₹67 Cr	₹61 Cr	-₹39 Cr	₹195 Cr	₹33 Cr	-₹187 Cr

Balance Sheet

Consolidated

Standalone

₹

%

Name

Equity And Liabilities

Share Capital

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014
—	—	—	—	—	—	—	—	—	—	—	—	—
₹31 Cr	₹31 Cr	₹29 Cr	₹29 Cr	₹14 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr
₹3283 Cr	₹3016 Cr	₹681 Cr	₹689 Cr	₹608 Cr	₹884 Cr	₹721 Cr	₹855 Cr	₹794 Cr	₹710 Cr	₹628 Cr	₹493 Cr	₹457 Cr
₹3283 Cr	₹3016 Cr	₹681 Cr	₹689 Cr	₹608 Cr	₹884 Cr	₹721 Cr	₹855 Cr	₹794 Cr	₹710 Cr	₹628 Cr	₹493 Cr	₹457 Cr
₹3313 Cr	₹3047 Cr	₹709 Cr	₹717 Cr	₹622 Cr	₹885 Cr	₹722 Cr	₹856 Cr	₹795 Cr	₹711 Cr	₹629 Cr	₹494 Cr	₹458 Cr
₹18 Cr	₹17 Cr	₹11 Cr	₹6 Cr	₹3 Cr	₹2 Cr	-₹2 Cr	₹35 Cr	₹29 Cr	₹21 Cr	₹12 Cr	₹3 Cr	₹1 Cr
₹0	₹0	₹78 Cr	₹115 Cr	₹13 Cr	₹0	₹10 Cr	₹45 Cr	₹17 Cr	₹0	₹52 Cr	₹78 Cr	₹18 Cr
₹0	₹0	₹0	₹0	₹0	₹1 Cr	₹0	₹0	₹0	₹0	₹6 L	₹0	₹0
-₹153 Cr	-₹189 Cr	-₹111 Cr	-₹6 Cr	₹20 Cr	₹27 Cr	₹33 Cr	₹35 Cr	₹34 Cr	₹21 Cr	₹39 Cr	₹25 Cr	₹25 Cr
₹955 Cr	₹102 Cr	₹1464 Cr	₹1111 Cr	₹1095 Cr	₹637 Cr	₹524 Cr	₹12 Cr	₹11 Cr	₹5 Cr	₹6 Cr	₹6 Cr	₹5 Cr
₹49 Cr	₹36 Cr	₹31 Cr	₹26 Cr	₹24 Cr	₹20 Cr	₹19 Cr	₹26 Cr	₹25 Cr	₹24 Cr	₹26 Cr	₹23 Cr	₹21 Cr
₹850 Cr	-₹52 Cr	₹1462 Cr	₹1246 Cr	₹1153 Cr	₹685 Cr	₹586 Cr	₹118 Cr	₹85 Cr	₹50 Cr	₹123 Cr	₹133 Cr	₹70 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—
₹602 Cr	₹643 Cr	₹532 Cr	₹567 Cr	₹590 Cr	₹341 Cr	₹423 Cr	₹210 Cr	₹244 Cr	₹147 Cr	₹151 Cr	₹153 Cr	₹122 Cr
₹345 Cr	₹180 Cr	₹253 Cr	₹246 Cr	₹238 Cr	₹84 Cr	₹110 Cr	₹119 Cr	₹85 Cr	₹79 Cr	₹104 Cr	₹83 Cr	₹46 Cr
₹73 Cr	₹14 Cr	₹368 Cr	₹388 Cr	₹338 Cr	₹86 Cr	₹130 Cr	₹182 Cr	₹143 Cr	₹183 Cr	₹136 Cr	₹156 Cr	₹139 Cr
₹74 Cr	₹58 Cr	₹58 Cr	₹65 Cr	₹107 Cr	₹68 Cr	₹67 Cr	₹14 Cr	₹8 Cr	₹8 Cr	₹7 Cr	₹20 Cr	₹7 Cr
₹1095 Cr	₹894 Cr	₹1211 Cr	₹1266 Cr	₹1272 Cr	₹580 Cr	₹730 Cr	₹525 Cr	₹480 Cr	₹417 Cr	₹396 Cr	₹412 Cr	₹315 Cr
₹5276 Cr	₹3905 Cr	₹3393 Cr	₹3235 Cr	₹3050 Cr	₹2152 Cr	₹2037 Cr	₹1535 Cr	₹1389 Cr	₹1200 Cr	₹1161 Cr	₹1042 Cr	₹845 Cr
₹99 Cr	₹92 Cr	₹89 Cr	₹82 Cr	₹98 Cr	₹22 Cr	₹20 Cr	₹27 Cr	₹25 Cr	₹13 Cr	₹20 Cr	₹18 Cr	₹15 Cr
₹73 Cr	₹14 Cr	₹492 Cr	₹537 Cr	₹358 Cr	₹97 Cr	₹175 Cr	₹269 Cr	₹173 Cr	₹195 Cr	₹213 Cr	₹255 Cr	₹166 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—
₹2445 Cr	₹2252 Cr	₹1893 Cr	₹1715 Cr	₹1542 Cr	₹1325 Cr	₹992 Cr	₹940 Cr	₹882 Cr	₹784 Cr	₹638 Cr	₹546 Cr	₹376 Cr
₹989 Cr	₹854 Cr	₹702 Cr	₹617 Cr	₹521 Cr	₹421 Cr	₹348 Cr	₹288 Cr	₹232 Cr	₹181 Cr	₹137 Cr	₹101 Cr	₹72 Cr
₹1456 Cr	₹1397 Cr	₹1191 Cr	₹1097 Cr	₹1021 Cr	₹904 Cr	₹644 Cr	₹652 Cr	₹649 Cr	₹603 Cr	₹501 Cr	₹444 Cr	₹304 Cr
₹177 Cr	₹160 Cr	₹195 Cr	₹103 Cr	₹31 Cr	₹17 Cr	₹57 Cr	₹0	₹0	₹0	₹7 Cr	₹0	₹22 Cr
₹14 L	₹14 L	₹14 L	₹14 L	₹39 L	₹53 L	₹56 L	₹9 Cr	₹12 Cr	₹4 L	₹18 Cr	₹0	₹0
₹14 L	₹14 L	₹14 L	₹14 L	₹39 L	₹53 L	₹56 L	₹9 Cr	₹12 Cr	₹4 L	₹18 Cr	₹0	₹0
₹76 Cr	₹61 Cr	₹56 Cr	₹96 Cr	₹86 Cr	₹44 Cr	₹36 Cr	₹40 Cr	₹26 Cr	₹21 Cr	₹51 Cr	₹37 Cr	₹52 Cr
₹7 Cr	₹9 Cr	₹10 Cr	₹14 Cr	₹20 Cr	₹29 Cr	₹50 Cr	₹99 L	₹51 L	₹3 Cr	₹0	₹0	₹0
₹1716 Cr	₹1631 Cr	₹1452 Cr	₹1311 Cr	₹1159 Cr	₹995 Cr	₹787 Cr	₹702 Cr	₹688 Cr	₹626 Cr	₹580 Cr	₹481 Cr	₹378 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—
₹0	₹0	₹0	₹0	₹0	₹19 Cr	₹6 Cr	₹0	₹0	₹0	₹0	₹0	₹0
₹756 Cr	₹681 Cr	₹630 Cr	₹730 Cr	₹722 Cr	₹430 Cr	₹398 Cr	₹268 Cr	₹295 Cr	₹244 Cr	₹289 Cr	₹261 Cr	₹192 Cr
₹797 Cr	₹770 Cr	₹834 Cr	₹845 Cr	₹884 Cr	₹531 Cr	₹582 Cr	₹473 Cr	₹334 Cr	₹295 Cr	₹259 Cr	₹273 Cr	₹241 Cr
₹1681 Cr	₹576 Cr	₹277 Cr	₹150 Cr	₹103 Cr	₹68 Cr	₹147 Cr	₹21 Cr	₹18 Cr	₹7 Cr	₹14 Cr	₹12 Cr	₹24 Cr
₹24 Cr	₹32 Cr	₹30 Cr	₹15 Cr	₹9 Cr	₹10 Cr	₹13 Cr	₹8 Cr	₹4 Cr	₹4 Cr	₹6 Cr	₹6 Cr	₹4 Cr
₹303 Cr	₹215 Cr	₹169 Cr	₹139 Cr	₹145 Cr	₹99 Cr	₹104 Cr	₹64 Cr	₹49 Cr	₹24 Cr	₹13 Cr	₹10 Cr	₹5 Cr
₹3560 Cr	₹2275 Cr	₹1941 Cr	₹1879 Cr	₹1864 Cr	₹1157 Cr	₹1250 Cr	₹833 Cr	₹701 Cr	₹574 Cr	₹580 Cr	₹561 Cr	₹466 Cr
₹2465 Cr	₹1381 Cr	₹730 Cr	₹613 Cr	₹592 Cr	₹577 Cr	₹520 Cr	₹308 Cr	₹221 Cr	₹157 Cr	₹184 Cr	₹149 Cr	₹151 Cr
₹5276 Cr	₹3905 Cr	₹3393 Cr	₹3235 Cr	₹3050 Cr	₹2152 Cr	₹2037 Cr	₹1535 Cr	₹1389 Cr	₹1200 Cr	₹1161 Cr	₹1042 Cr	₹845 Cr
₹216	₹199	₹50	₹50	₹87	₹6,801	₹5,554	₹7,286	₹6,763	₹6,053	₹5,356	₹4,204	₹3,901
₹216	₹199	₹50	₹50	₹43	₹62	₹50	₹66	₹61	₹55	₹49	₹38	₹35

Cash Flow

Consolidated

Standalone

₹

%

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014
₹382 Cr	₹345 Cr	-₹45 Cr	₹150 Cr	-₹193 Cr	₹172 Cr	₹114 Cr	₹126 Cr	₹150 Cr	₹143 Cr	₹89 Cr	₹77 Cr	₹126 Cr
₹164 Cr	₹172 Cr	₹556 Cr	₹158 Cr	₹631 Cr	₹144 Cr	₹78 Cr	₹74 Cr	₹68 Cr	₹67 Cr	₹64 Cr	₹59 Cr	₹27 Cr
₹722 Cr	₹30 Cr	₹50 Cr	-₹34 Cr	-₹352 Cr	-₹137 Cr	-₹115 Cr	-₹172 Cr	-₹13 Cr	-₹16 Cr	-₹11 Cr	-₹45 Cr	-₹135 Cr
₹1269 Cr	₹546 Cr	₹561 Cr	₹274 Cr	₹87 Cr	₹179 Cr	₹77 Cr	₹28 Cr	₹204 Cr	₹194 Cr	₹141 Cr	₹90 Cr	₹17 Cr
₹1181 Cr	₹465 Cr	₹498 Cr	₹177 Cr	₹32 Cr	₹134 Cr	₹28 Cr	-₹23 Cr	₹157 Cr	₹156 Cr	₹89 Cr	₹72 Cr	-₹15 Cr
-₹930 Cr	-₹548 Cr	-₹330 Cr	-₹305 Cr	-₹235 Cr	-₹109 Cr	-₹190 Cr	-₹49 Cr	-₹111 Cr	-₹128 Cr	-₹123 Cr	-₹150 Cr	-₹55 Cr
₹34 Cr	₹73 Cr	-₹108 Cr	₹125 Cr	₹236 Cr	-₹95 Cr	₹233 Cr	₹75 Cr	-₹35 Cr	-₹34 Cr	₹37 Cr	₹66 Cr	₹89 Cr
₹285 Cr	-₹10 Cr	₹60 Cr	-₹4 Cr	₹33 Cr	-₹70 Cr	₹71 Cr	₹3 Cr	₹11 Cr	-₹7 Cr	₹4 Cr	-₹11 Cr	₹18 Cr
₹101 Cr	₹111 Cr	₹52 Cr	₹55 Cr	₹22 Cr	₹92 Cr	₹21 Cr	₹18 Cr	₹7 Cr	₹14 Cr	₹10 Cr	₹21 Cr	₹3 Cr
₹0	₹0	-₹38 L	₹0	₹0	₹51 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹386 Cr	₹101 Cr	₹111 Cr	₹52 Cr	₹55 Cr	₹22 Cr	₹92 Cr	₹21 Cr	₹18 Cr	₹7 Cr	₹14 Cr	₹10 Cr	₹21 Cr

Fundamental Ratios

Consolidated

Standalone

No results found

Akums Drugs & Pharmaceuticals Share Price

814.65+0.00 (+1.66%)

+84.60% past 1 Year

02 Jan 25+9D

Bid/Ask

Price

Greeks

Stradle

Custom

CALLS

Qty/ots

PUTS

Sign in to View

Open a free Demat account in minutes to start investing and screening .

Login Sign Up

Akums Drugs & Pharmaceuticals Share Price

814.65+0.00 (+1.66%)

+84.60% past 1 Year

Technical meters

Oscillators

Strong SellSellNeutralBuyStrong Buy

Bullish signals: 5

Bearish signals: 1 out of 9 oscillators

RSI

59.19Buy

STOCH %K

73.86Neutral

MACD Level(12,26)

18.14Buy

Ultimate Oscillator

45.02Sell

Aroon Oscillator

74.00Buy

BOP

0.58Buy

CCI

46.86Neutral

Williams %R

-26.14Neutral

Momentum

49.00Buy

Moving averages

Strong SellSellNeutralBuyStrong Buy

Bullish signals: 9

Bearish signals: 0 out of 9 moving averages

EMA 9

808.74Buy

SMA 9

814.17Buy

EMA 21

793.92Buy

SMA 21

789.00Buy

EMA 50

754.52Buy

SMA 50

753.01Buy

EMA 200

625.18Buy

SMA 200

577.87Buy

WMA 20

803.72Buy

Pivot

Classic

Resistance 5

922.17

Resistance 4

893.52

Resistance 3

864.87

Resistance 2

836.22

Resistance 1

818.78

Pivot

807.57

Support 1

790.13

Support 2

778.92

Support 3

750.27

Support 4

721.62

Support 5

692.97

High & lows

1 Day

1 Week

1 Month

3 Months

6 Months

Year to Date

1 Year

3 Years

5 Years

10 Years

All Time

Low

796.30

733.15

650.25

498.80

409.30

405.00

High

818.00

825.00

838.80

1175.90

Returns

+0.00

+1.55

+60.00

+156.45

+298.70

+361.25

+373.35

—

+89.65

Beta

—

Std. deviation %

—

Sign in to view

Open a free Demat account in minutes to start investing and screening .

Akums Drugs & Pharmaceuticals Share Price

814.65+0.00 (+1.66%)

+84.60% past 1 Year

Shareholding summary

Promoters

75.26%

FII

1.91%

DII

3.67%

MF

9.77%

Others

9.39%

Promoters

FII

DII

MF

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
75.26%	75.26%	75.26%	75.26%	75.26%	75.26%
1.91%	1.38%	1.14%	2.27%	4.24%	5.77%
3.67%	3.41%	3.18%	2.84%	2.12%	1.28%
9.77%	10.95%	11.23%	6.44%	6.73%	6.11%
9.39%	9.00%	9.19%	13.19%	11.65%	11.58%

Bulk & block deals

Name

Icici Prudential Mutual Fund

Ruby Qc Investment Holdings Pte.ltd.

Icici Prudential Mutual Fund

Ruby Qc Investment Holdings Pte.ltd.

Smallcap World Fund Inc

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
22 Dec 2025	Purchase	311.52 Cr	₹428	72.79 L	Bulk	4.624404	NSE
22 Dec 2025	Sell	311.52 Cr	₹428	72.79 L	Bulk	4.624404	NSE
22 Dec 2025	Purchase	311.52 Cr	₹428	72.79 L	Block	4.624404	NSE
22 Dec 2025	Sell	311.52 Cr	₹428	72.79 L	Block	4.624404	NSE
06 Aug 2024	Purchase	194.98 Cr	₹753.84	25.87 L	Bulk	1.643354	NSE

Insider trading & SAST

Client name

Ruby Qc Investment Holdings Pte Ltd

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
06 Jan 2026	Other	Disposal	4.62	—	0	—	72.79 L	22 Dec 2025	Block Deal	—	SAST	29(2)	—

Akums Drugs & Pharmaceuticals Share Price

814.65+0.00 (+1.66%)

+84.60% past 1 Year

Akums Drugs and Pharmaceuticals is a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas. As one of the

Corporate Actions

Date

Type

Details

2026-07-03

Dividend

1.0

2026-07-03

Dividend

2.0

Company details

Registered office

304 Mohan Place L S C, Block C Saraswati Vihar New Delhi Delhi PIN: 110034 Tel No: 011- 47511000 Fax No: 011 27023256 Email: [email protected] Internet: www.akums.in

Registrars

PIN: Tel No: Fax No: Email:

Management

Dharamvir Malik, Company Secretary & Compliance Officer

Sanjeev Jain, Managing Director

Sandeep Jain, Managing Director

Sanjay Sinha, Whole Time Director

Sunil Kumar Thakur, Non Executive Director

Kewal Handa, Non Executive Independent Director

Matangi Gowrishankar, Non Executive Independent Director

Satwinder Singh, Non Executive Independent Director

Anil Amin, Non Executive Independent Director